SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

VOLINIA, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.630
AS - Asia 12.164
EU - Europa 5.968
SA - Sud America 2.007
AF - Africa 286
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 10
Totale 46.080
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.204
SG - Singapore 4.619
CN - Cina 2.922
BR - Brasile 1.554
VN - Vietnam 1.478
UA - Ucraina 1.124
DE - Germania 1.097
HK - Hong Kong 1.056
IT - Italia 854
TR - Turchia 850
GB - Regno Unito 639
FI - Finlandia 449
PL - Polonia 355
FR - Francia 350
SE - Svezia 346
RU - Federazione Russa 341
IN - India 242
JP - Giappone 206
MX - Messico 204
CA - Canada 161
BD - Bangladesh 159
ID - Indonesia 157
AR - Argentina 156
ZA - Sudafrica 92
ES - Italia 78
IQ - Iraq 78
NL - Olanda 75
EC - Ecuador 67
CO - Colombia 62
AT - Austria 56
PK - Pakistan 52
BE - Belgio 48
UZ - Uzbekistan 46
VE - Venezuela 45
CL - Cile 40
SA - Arabia Saudita 40
MA - Marocco 39
LT - Lituania 34
TN - Tunisia 32
PY - Paraguay 30
KE - Kenya 27
PH - Filippine 27
IR - Iran 25
EG - Egitto 22
UY - Uruguay 22
CZ - Repubblica Ceca 20
MY - Malesia 19
ET - Etiopia 18
JO - Giordania 18
AE - Emirati Arabi Uniti 16
PS - Palestinian Territory 16
IL - Israele 15
AZ - Azerbaigian 14
NP - Nepal 14
PE - Perù 14
RO - Romania 14
AU - Australia 13
JM - Giamaica 13
DZ - Algeria 12
KR - Corea 12
AL - Albania 11
BO - Bolivia 10
CR - Costa Rica 10
KZ - Kazakistan 10
GR - Grecia 9
OM - Oman 9
TH - Thailandia 9
CH - Svizzera 8
NG - Nigeria 8
TW - Taiwan 8
HU - Ungheria 7
LB - Libano 7
BG - Bulgaria 6
BH - Bahrain 6
DO - Repubblica Dominicana 6
NI - Nicaragua 6
PA - Panama 6
RS - Serbia 6
DK - Danimarca 5
GA - Gabon 5
HN - Honduras 5
MD - Moldavia 5
PT - Portogallo 5
SN - Senegal 5
SY - Repubblica araba siriana 5
CI - Costa d'Avorio 4
GE - Georgia 4
KW - Kuwait 4
LV - Lettonia 4
LY - Libia 4
SK - Slovacchia (Repubblica Slovacca) 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
GT - Guatemala 3
GY - Guiana 3
IE - Irlanda 3
KG - Kirghizistan 3
SR - Suriname 3
TG - Togo 3
Totale 46.016
Salva come PNG Salva come JPEG
Città #
Fairfield 3.009
Singapore 2.903
Woodbridge 2.710
Ashburn 2.605
Houston 1.604
Seattle 1.248
Jacksonville 1.241
Ann Arbor 1.190
Chandler 1.097
San Jose 1.073
Hong Kong 1.034
Wilmington 996
Cambridge 993
Beijing 849
Santa Clara 824
Ho Chi Minh City 463
Izmir 450
Dallas 428
Nanjing 359
Los Angeles 341
Warsaw 339
Hanoi 333
Princeton 285
Addison 248
San Diego 244
New York 240
Lauterbourg 239
Ferrara 233
Munich 202
Boardman 198
Tokyo 196
Milan 153
São Paulo 150
Helsinki 139
Council Bluffs 133
Shanghai 126
Nanchang 119
Mexico City 110
Jakarta 102
Orem 96
Buffalo 94
Shenyang 93
Dearborn 91
London 91
Hebei 84
Tianjin 84
The Dalles 82
Hefei 80
Bremen 71
Turku 70
Da Nang 67
Denver 65
Atlanta 63
Falls Church 63
Haiphong 60
Mountain View 59
Chicago 58
Jiaxing 57
San Mateo 57
Frankfurt am Main 56
Johannesburg 56
Stockholm 55
Brooklyn 54
Jinan 52
Changsha 50
Rio de Janeiro 49
Toronto 49
Montreal 47
Redwood City 47
Falkenstein 45
Brussels 44
Chennai 43
Amsterdam 41
Moscow 41
Nuremberg 40
Columbus 39
Kunming 39
Tashkent 39
Boston 38
Guangzhou 38
Mumbai 38
Belo Horizonte 37
Manchester 35
Baghdad 33
Poplar 33
Norwalk 31
San Francisco 31
Dong Ket 30
Phoenix 30
Ankara 29
Ningbo 29
Brasília 28
Des Moines 27
Orange 27
Vienna 27
Porto Alegre 26
Hangzhou 25
Quito 25
Dhaka 24
Ottawa 24
Totale 32.242
Salva come PNG Salva come JPEG
Nome #
Loss of miR-204 expression is a key event in melanoma 280
Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. 262
Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors 252
Correlation of expression between different IMAGE clones from the same UniGene cluster 250
miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells 249
miRNA signatures associate with pathogenesis and progression of osteosarcoma. 246
A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis 246
MicroRNA Expression Signatures in Solid Malignancies 244
Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a 242
Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset 235
Identification of microRNA activity by Targets' Reverse EXpression. 234
A microRNA signature for a BMP2-induced osteoblast lineage commitment program 233
A miRNA signature for defining aggressive phenotype and prognosis in gliomas 232
Reovirus-associated reduction of microRNA-let-7d is related to the increased apoptotic death of cancer cells in clinical samples 229
Association between idiopathic hearing loss and mitochondrial DNA mutations: a study on 169 hearing-impaired subjects 226
A DE NOVO GENE ALTERATION CAUSING VON WILLEBRAND DISEASE 223
miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia 222
The downregulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state. 220
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1 218
GAMES identifies and annotates mutations in next-generation sequencing projects 216
Reprogramming of miRNA networks in cancer and leukemia 215
Microevolution in Ferrara: Isonymy 1890–1990 214
The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma 213
Analysis of osteoblast-like MG63 cells' response to a rough implant surface by means of DNA microarray 212
A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia 212
MicroRNA expression profiling in human Barrett's carcinogenesis. 212
In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation 212
MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia 211
p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. 210
Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer 206
B-cell malignancies in microRNA Eμ-miR-17~92 transgenic mice 206
MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma 204
Analysis of Differential Expression of TG2 Variants During Treatment with Retinoic Acid Highlights a New 3'-Terminal Transcript and Putatively Involved Proteins 203
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells 203
miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions. 202
A long non-coding RNA inside the type 2 transglutaminase gene tightly correlates with the expression of its transcriptional variants 200
RNA analysis indicates tight correlation between the expression of a long non coding RNA and the TG2 mRNA levels 199
Onconase mediated NFKβ downregulation in malignant pleural mesothelioma 199
A Multidisciplinary Approach Establishes a Link between Transglutaminase 2 and the Kv10.1 Voltage-Dependent K+ Channel in Breast Cancer 198
Prion proteins (PRNP and PRND) are over-expressed in osteosarcoma 198
Espressione dei MicroRNA nei carcinomi mammari 196
Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts 196
Strong inverse correlation between MicroRNA-125b and human papillomavirus DNA in productive infection 194
Inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations 193
CG Dinucleotides of class II MHC genes are mutation hot-spots 192
TOM: Transcriptomics of OMIM. 191
Circulating tumor cells share RNA modules with early embryo trophectoderm and with metastatic cancer 191
Significance of Aberrant Expression of MicroRNAs in Cancer Cells 190
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B 189
Profiling of the Predicted Circular RNAs in Ductal In Situ and Invasive Breast Cancer: A Pilot Study 188
SNPs and somatic mutation on long non-coding RNA: New frontier in the cancer studies? 187
Partial gene deletion in a family with factor X deficiency 186
Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. 185
Comparison of microRNA deep sequencing of matched formalin-fixed paraffin-embedded and fresh frozen cancer tissues. 185
GAS6 expression identifies high-risk adult AML patients: potential implications for therapy. 185
A RECURRENT AMINOACID SUBSTITUTION AND A PARTIAL GENE DELETION IN SEVERE HEMOPHILIA A 185
Implications of the miR-10 family in chemotherapy response of NPM1-mutated AML 185
Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia 184
Metabolic Profiling of Breast Cancer Cell Lines: Unique and Shared Metabolites 183
WWOX and p53 dysregulation synergize to drive the development of osteosarcoma 183
Involvement of non-coding RNAs and transcription factors in the induction of Transglutaminase isoforms by ATRA 183
The miR-1792 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes 182
CHARACTERIZATION OF THE PSEUDOGENIC REGION OF VON WILLEBRAND FACTOR BY MOLECULAR CLONING AND "IN SITU" HYBRIDIZATION 181
The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model 181
Expression profiles of craniosynostosis-derived fibroblasts 180
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas 180
Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer 179
Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells 179
Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway 177
The role of microRNA genes in papillary thyroid carcinoma 177
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis 174
GOAL: automated gene ontology analisys of expression profiles. 173
MicroRNA profiles discriminate among colon cancer metastasis 172
MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer 171
SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcome 170
Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer 169
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 168
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia 167
The network of non-coding RNAs in cancer drug resistance 167
ATRA modulates the expression of alternative Transglutaminase 2 in brain tumors through interactions between regulatory factors and intronic regions 167
Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells 167
UC.183, UC.110, and UC.84 ultra-conserved RNAs are mutually exclusive with mir-221 and are engaged in the cell cycle circuitry in breast cancer cell lines 167
Suppression of MicroRNA-9 by Mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity 166
Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis 166
Dysregulation of Transglutaminase type 2 through GATA3 defines aggressiveness and Doxorubicin sensitivity in breast cancer 166
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study 165
Inhibition of the lncRNA Coded within Transglutaminase 2 Gene Impacts Several Relevant Networks in MCF-7 Breast Cancer Cells 165
Modulation of mismatch repair and genomic stability by miR-155 164
The WWOX tumor suppressor is essential for postnatal survival and normal bone metabolism 162
Functional Implications of MicroRNAs in Acute Myeloid Leukemia by Integrating MicroRNA and Messenger RNA Expression Profiling 161
MSC-regulated microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis 161
The network of non-coding RNAs and their molecular targets in breast cancer 161
Mutational landscape and gene-expression patterns in adult acute myeloid leukemias with monosomy 7 as a sole abnormality 159
MiR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse model 159
miR-130A as a diagnostic marker to differentiate malignant mesothelioma from lung adenocarcinoma in pleural effusion cytology 159
Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARβ and tumor regression 159
GAM/ZFp/ZNF512B is central to a gene sensor circuitry involving cell-cycle regulators, TGFβ effectors, Drosha and microRNAs with opposite oncogenic potentials 158
Prognostic gene mutations and distinct gene- and microRNA-expression signatures in acute myeloid leukemia with a sole trisomy 8 157
Circular RNAs Could Encode Unique Proteins and Affect Cancer Pathways 156
Exploiting supervised and unsupervised learning techniques for profiling cancer data 156
Totale 19.387
Salva come PNG Salva come JPEG
Categoria #
all - tutte 185.111
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.204
Totale 187.315
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.187 0 0 0 0 0 0 0 0 0 484 479 224
2021/20223.197 174 363 351 56 137 117 155 116 93 243 293 1.099
2022/20232.647 275 114 90 300 443 409 115 247 367 26 166 95
2023/20241.240 155 203 61 38 74 177 63 61 31 25 51 301
2024/20255.665 155 154 476 211 697 441 186 393 931 626 768 627
2025/202615.397 1.506 749 1.585 2.156 2.337 990 1.991 990 1.669 1.424 0 0
Totale 46.484